| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $6.9M | -51.2% |
| SG&A Expense | $10.0M | -19.4% |
| Operating Income | -$34.5M | -29.8% |
| Interest Expense | $12K | -87.9% |
| Income Tax | -$1.5M | -1243.6% |
| Net Income | -$16.1M | +39.7% |
| EPS (Basic) | -$2.21 | +47.3% |
| EPS (Diluted) | -$2.21 | +47.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5.0M | -76.4% |
| Total Assets | $14.5M | -70.7% |
| Current Liabilities | $11.2M | -45.8% |
| Long-term Debt | $2.6M | — |
| Total Liabilities | $12.7M | -59.0% |
| Stockholders' Equity | -$113K | -100.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | -11.7% |
| Capital Expenditures | $18K | — |
| Investing Cash Flow | $791K | -20.9% |
| Financing Cash Flow | -$1.3M | -103.9% |
| Free Cash Flow | -$16.8M | — |